Dualitybio Inc.
Clinical trials sponsored by Dualitybio Inc., explained in plain language.
-
New hope for advanced breast cancer: phase 3 trial tests DB-1303 against current therapy
Disease control OngoingThis study tests whether a new drug, DB-1303, works better than the current standard treatment T-DM1 for people with advanced HER2-positive breast cancer that cannot be removed by surgery or has spread. About 228 adults who have already tried trastuzumab and a taxane will be rand…
Phase: PHASE3 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 17, 2026 01:14 UTC
-
New hope for advanced cancer patients in early drug trial
Disease control OngoingThis study tests a new drug called DB-1305/BNT325 in adults with advanced solid tumors that have not responded to standard treatments or have no standard options. The goal is to find a safe dose and see if the drug can shrink tumors. About 1,100 participants will take part in thi…
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New hope for Hard-to-Treat breast cancer: targeted drug shows promise in Late-Stage trial
Disease control OngoingThis phase 3 study tests a new drug, DB-1303, against standard chemotherapy in about 541 people with a specific type of advanced breast cancer (HER2-low, HR+). Participants' cancer has stopped responding to hormone therapy. The goal is to see if DB-1303 can delay cancer growth be…
Phase: PHASE3 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC